Global IVL market forecast to reach $3.8B by 2032, driven by rising calcified cardiovascular disease and adoption of ...

NEW ORLEANS — Extracorporeal shockwave lithotripsy, once the gold standard for removing smaller kidney stones, has fallen out of favor, in part because it might be less effective than ureteroscopy, ...

The demand for lithotripsy procedures is expected to increase in the coming years. This expected increase is supported by a review of the Global Lithotripsy Devices Market. It is forecasted to grow at ...

Add Yahoo as a preferred source to see more of our stories on Google. Kevin Wininger, a computed tomography technologist and cardiovascular technologist at University Hospital’s Samaritan Medical ...

Q: Which Doctor Should I Consult for ESWL or Lithotripsy? A: Consult Urologist if you need ESWL or lithotripsy or treatment for stones in the urinary tract. A: Once the treatment is done, there maybe ...

When it comes to treating kidney stones, less invasive may not always be better, according to new research from Duke Medicine. In a direct comparison of shock wave lithotripsy vs. ureteroscopy – the ...

On July 30, 2008, CMS issued its final rule regarding the Hospital Inpatient Prospective Payment System (IPPS). CMS elected to allow healthcare service providers until October 1, 2009 to restructure ...

PAD patients with severe calcification of the external and common iliac arteries who require TAVI can undergo a successful delivery of the device when it is facilitated by pretreatment with ...

December 3, 2009 — For shock wave lithotripsy (SWL), potential benefits in treating renal stones outweigh the foreseeable risks, according to a white paper from the American Urological Association ...

Kidney stones are a common condition in the U.S. – about 1 in 10 Americans get them. Passing a kidney stone can be quite painful. It can cause severe, sharp pain in the side and back, below the rib, ...

Please provide your email address to receive an email when new articles are posted on . In patients with calcified peripheral artery lesions treated with a drug-coated balloon, those who were ...

BOSTON--(BUSINESS WIRE)--AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced today that it ...